News

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Aspen Aerogels Inc (Symbol: ASPN), where a total of 9,043 contracts have traded so far, representing approximately 904,300 underlying shares. That amounts to about 78.4% of ASPN's average daily trading volume over the past month of 1.2 million shares. Particularly high volume was seen for the $40 strike call option expiring August 16, 2024, with 4,042 contracts trading so far today, representing approximately 404,200 underlying shares of ASPN. Below is a chart showing ASPN's trailing twelve month trading history, with the $40 strike highlighted in orange:

CVS Health Corporation (Symbol: CVS) saw options trading volume of 97,044 contracts, representing approximately 9.7 million underlying shares or approximately 71.3% of CVS's average daily trading volume over the past month, of 13.6 million shares. Particularly high volume was seen for the $62 strike call option expiring June 07, 2024, with 32,593 contracts trading so far today, representing approximately 3.3 million underlying shares of CVS. Below is a chart showing CVS's trailing twelve month trading history, with the $62 strike highlighted in orange:

And Capri Holdings Ltd (Symbol: CPRI) saw options trading volume of 8,032 contracts, representing approximately 803,200 underlying shares or approximately 69.6% of CPRI's average daily trading volume over the past month, of 1.2 million shares. Particularly high volume was seen for the $45 strike call option expiring January 17, 2025, with 2,536 contracts trading so far today, representing approximately 253,600 underlying shares of CPRI. Below is a chart showing CPRI's trailing twelve month trading history, with the $45 strike highlighted in orange:

For the various different available expirations for ASPN options, CVS options, or CPRI options, visit StockOptionsChannel.com.

Today's Most Active Call & Put Options of the S&P 500 »

Also see:

Semiconductors Dividend Stocks
EHTH YTD Return
Funds Holding NRE

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.